Arch Biopartners Inc.
ARCH.V
TSX
Corporate Info
647-428-7031
27 Street Clair Avenue East
PO Box 305
Toronto, ON M4T 2M5
PO Box 305
Toronto, ON M4T 2M5
Canada
--
Details
Health Care
Pharmaceuticals, Biotechnology and Life Sciences
Business Decription
Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.